{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:03:59Z","timestamp":1769573039979,"version":"3.49.0"},"reference-count":21,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2025,9,1]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Macrolides are known to play a key role in the treatment of nontuberculous mycobacteria. However, the optimal combination and number of drugs remains uncertain. N\n                    <jats:sc>agawawa<\/jats:sc>\n                    <jats:italic>et al.<\/jats:italic>\n                    and Z\n                    <jats:sc>weijpfenning<\/jats:sc>\n                    <jats:italic>et al.<\/jats:italic>\n                    investigated these questions in two randomised controlled trials exploring treatment regimens for\n                    <jats:italic>Mycobacterium avium<\/jats:italic>\n                    complex (MAC) infections, while N\n                    <jats:sc>guyen<\/jats:sc>\n                    <jats:italic>et al<\/jats:italic>\n                    . summarised some of these questions in a meta-analysis. N\n                    <jats:sc>agawawa<\/jats:sc>\n                    <jats:italic>et al.<\/jats:italic>\n                    compared an intermittent three-drug regimen to daily therapy, while Z\n                    <jats:sc>weijpfenning<\/jats:sc>\n                    <jats:italic>et al.<\/jats:italic>\n                    compared rifampicin or clofazimine as adjuncts to ethambutol and a macrolide. Tolerance levels for intermittent therapy were not significantly superior to those of daily therapy, while a clofazimine\u2013ethambutol\u2013macrolide regimen was non-inferior to one including rifampicin. Finally, N\n                    <jats:sc>guyen<\/jats:sc>\n                    <jats:italic>et al<\/jats:italic>\n                    . conclude that a two-drug regimen may be a viable option for treating MAC infections.\n                  <\/jats:p>","DOI":"10.1183\/20734735.0254-2025","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:50:16Z","timestamp":1769525416000},"page":"250254","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment strategies for\n                    <i>Mycobacterium avium<\/i>\n                    pulmonary disease"],"prefix":"10.1183","volume":"22","author":[{"given":"Rannv\u00e1","family":"Winther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-3948","authenticated-orcid":false,"given":"S\u00f8ren","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Fl\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2026012706501367000_22.1.250254.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.10.003"},{"key":"2026012706501367000_22.1.250254.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2026012706501367000_22.1.250254.3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02029"},{"key":"2026012706501367000_22.1.250254.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.10.002"},{"key":"2026012706501367000_22.1.250254.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.10.013"},{"key":"2026012706501367000_22.1.250254.6","doi-asserted-by":"crossref","first-page":"108055","DOI":"10.1016\/j.rmed.2025.108055","article-title":"Clinical characteristics and diagnostic practices in nontuberculous mycobacterial pulmonary disease: insights from Denmark","volume":"241","author":"Dahl","year":"2025","journal-title":"Respir Med"},{"key":"2026012706501367000_22.1.250254.7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0095-4543(21)01262-8","article-title":"The many faces of pulmonary aspergillosis","volume":"12","author":"Tenholder","year":"1985","journal-title":"Prim Care"},{"key":"2026012706501367000_22.1.250254.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00535-2020"},{"key":"2026012706501367000_22.1.250254.9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/17476348.2021.1887734","article-title":"A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective","volume":"15","author":"Ali","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2026012706501367000_22.1.250254.10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12890-023-02460-1","article-title":"Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data","volume":"23","author":"Hoefsloot","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026012706501367000_22.1.250254.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02210-2023"},{"key":"2026012706501367000_22.1.250254.12","doi-asserted-by":"crossref","first-page":"638306","DOI":"10.3389\/fmed.2021.638306","article-title":"Role of clofazimine in treatment of Mycobacterium avium complex","volume":"8","author":"Nasiri","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026012706501367000_22.1.250254.13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad682"},{"key":"2026012706501367000_22.1.250254.14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1513\/AnnalsATS.202406-626OC","article-title":"Intermittent versus daily therapy for noncavitary Mycobacterium avium complex pulmonary disease: an open-label randomized trial","volume":"22","author":"Nakagawa","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"2026012706501367000_22.1.250254.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.11.038"},{"key":"2026012706501367000_22.1.250254.16","doi-asserted-by":"crossref","first-page":"102711","DOI":"10.1016\/j.jiph.2025.102711","article-title":"Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: a systematic review and meta-analysis","volume":"18","author":"Nguyen","year":"2025","journal-title":"J Infect Public Health"},{"key":"2026012706501367000_22.1.250254.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1318OC"},{"key":"2026012706501367000_22.1.250254.18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2024.03.023","article-title":"Nationwide increasing incidence of nontuberculous mycobacterial diseases among adults in Denmark: eighteen years of follow-up","volume":"166","author":"Pedersen","year":"2024","journal-title":"Chest"},{"key":"2026012706501367000_22.1.250254.19","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.110957"},{"key":"2026012706501367000_22.1.250254.20","doi-asserted-by":"crossref","first-page":"13295","DOI":"10.1038\/s41598-024-64029-0","article-title":"Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria","volume":"14","author":"Biciusca","year":"2024","journal-title":"Sci Rep"},{"key":"2026012706501367000_22.1.250254.21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/ph18060891","article-title":"M. avium complex pulmonary infections: therapeutic obstacles and progress in drug development","volume":"18","author":"Charrier","year":"2025","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0254-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:50:17Z","timestamp":1769525417000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0254-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,27]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1183\/20734735.0254-2025"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0254-2025","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}